Product Information
QC FAMOTIDINE 20 MG TABLET is a generic product labeled by Chain Drug Marketing Association, priced at $0.1382 per EA under NDC 83324000850. Its NADAC has been published 96 times since Dec 4, 2024.
FDA first approved this application on Nov 8, 2021.
Strength
20 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324000850
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FAMOTIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA215766FDA Approved
11/8/2021
On Market Since
3/6/2024
Pharmacological Classes
Price Statistics
The NADAC for QC FAMOTIDINE 20 MG TABLET has been published 96 times since Dec 4, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1382 per EA |
|---|---|
| All-time high | $0.1487 (Jun 11, 2025) |
| All-time low | $0.1370 (Dec 4, 2024) |
| 52-week high | $0.1480 |
| 52-week low | $0.1382 |
| Median price | $0.1444 |
| Average price | $0.1439 |
| Largest weekly change | +3.9% (Dec 18, 2024) |
| Weeks tracked | 96 |
| Tracking since | Dec 4, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 79% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
famotidine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC FAMOTIDINE 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QC FAMOTIDINE 20 MG TABLET, manufactured by Chain Drug Marketing Association, is $0.1382 per EA (NDC 83324000850), effective Sep 30, 2026.
How has the price of QC FAMOTIDINE 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for QC FAMOTIDINE 20 MG TABLET has held within roughly two percent of its current level. It has been tracked across 96 weekly CMS publications since Dec 4, 2024.
What are the highest and lowest recorded NADAC prices for QC FAMOTIDINE 20 MG TABLET?
Since Dec 4, 2024, the NADAC for QC FAMOTIDINE 20 MG TABLET has ranged from a low of $0.1370 (Dec 4, 2024) to a high of $0.1487 (Jun 11, 2025), with a median of $0.1444 per EA.
Are there cheaper alternatives to QC FAMOTIDINE 20 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FAMOTIDINE 20 MG TABLET, is $0.0289 per EA — about 79% below QC FAMOTIDINE 20 MG TABLET.
Who manufactures QC FAMOTIDINE 20 MG TABLET?
QC FAMOTIDINE 20 MG TABLET (NDC 83324000850) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.